🔬 Our position: No two cases of hair loss are alike. Pattern, hormones, nutrition, scalp environment and lifestyle all matter. Our protocol is built to surface those drivers — not to push a single product on every patient.
1. The Hairsncares Hybrid Model — AI + Dermatologist
Hairsncares operates on a hybrid clinical model: an AI engine that handles structured data intake and pattern recognition, paired with a panel of NMC-registered dermatologists who review every clinically meaningful output. The AI's job is triage and structure. The dermatologist's job is judgement, prescription and accountability.
This separation is deliberate. Indian regulation under the Telemedicine Practice Guidelines, 2020 places clinical responsibility on the registered medical practitioner — not on software. Our workflow respects that line.
Why a hybrid model
- AI strengths: consistent intake, pattern matching across thousands of cases, removal of time pressure during history taking.
- Dermatologist strengths: clinical correlation, differential diagnosis, prescription authority, accountability under the Medical Council framework.
- Combined outcome: the patient gets an organised, complete assessment delivered faster — without losing the safety net of a real doctor.
2. Diagnosis Framework — Looking for Root Causes
Hair loss is rarely a single problem. We work through a structured framework rather than jumping to a product recommendation.
Pattern Identification
- Androgenetic alopecia (male / female pattern)
- Telogen effluvium (acute / chronic)
- Alopecia areata
- Traction alopecia
- Cicatricial (scarring) alopecia — flagged for in-person referral
Scalp Environment
- Seborrheic dermatitis & dandruff load
- Folliculitis or scalp inflammation
- Sebum balance and product build-up
- Hairline density and miniaturisation patterns (where photos are submitted)
Lifestyle & Nutritional Drivers
- Recent illness, fever, surgery or COVID episode (telogen triggers)
- Restrictive diets, recent weight loss, vegetarian iron status
- Sleep, stress and shift-work patterns
- Heat tools, chemical treatments, hairstyle traction
Hormonal & Systemic Factors
- Thyroid (hypo/hyper) — TSH screening recommended where indicated
- PCOS / hyperandrogenism in female patients
- Postpartum and post-menopausal phases
- Iron, ferritin, vitamin D, vitamin B12 — common reversible drivers in Indian patients
🧪 Where blood work or in-person trichoscopy is needed, the dermatologist will recommend it before issuing any prescription. We will not recommend a long-term Schedule H drug on questionnaire data alone.
3. The 5-Step Treatment Protocol
Step 1 — AI Diagnosis (≈90 seconds)
You complete a structured questionnaire on the Hairsncares AI Hair Test. Optional scalp photographs add visual signal. The AI returns a categorised pattern, severity stage (Norwood for men / Ludwig for women) and a list of drivers worth investigating.
Step 2 — Dermatologist Review
The AI report is reviewed by a dermatologist on our panel. They confirm or correct the categorisation, flag conditions needing in-person evaluation, and decide whether prescription medicines are appropriate. The patient is never prescribed by the AI.
Step 3 — Personalised Treatment Plan
Once a clinical picture is agreed, we generate a written plan that specifies: topical actives (e.g. minoxidil, peptide complexes), systemic options where indicated under prescription, scalp-care routines, nutritional support and timeline expectations.
Step 4 — Products & In-Clinic Therapy
OTC and cosmetic actives can be ordered directly from the platform. Schedule H / H1 prescription items require a valid Rx, uploaded and verified before dispatch. In-clinic procedures (PRP, mesotherapy, transplant evaluation) are routed to our partner clinic in Mumbai when the patient prefers in-person care.
Step 5 — Progress Tracking & Iteration
We track at 4, 12 and 24 weeks. Photographs, shedding count and patient-reported outcomes feed into a follow-up dermatologist review. Plans are tightened, scaled back or escalated based on response — not on a fixed sales calendar.
4. Conditions We Routinely Address
Hair Fall (Diffuse Shedding)
Often telogen effluvium triggered by illness, post-COVID, postpartum changes, iron deficiency or stress. Most cases are self-limiting if the trigger is addressed. We screen for reversible drivers before recommending long-term therapy.
Pattern Baldness — Male
Androgenetic alopecia staged on the Norwood scale. Evidence-based options include topical minoxidil, oral or topical finasteride (Rx, dermatologist-supervised), peptide formulations and procedural therapies. Outcomes plateau without ongoing maintenance — we say so explicitly.
Female Hair Thinning
Female-pattern hair loss staged on Ludwig. Hormonal screening is part of the workup. Treatment options differ from the male protocol — finasteride is generally avoided in women of reproductive age. Pregnancy and lactation safety profiles are flagged in every Rx review.
PCOS-related Hair Loss
Co-managed with hormonal correction where confirmed. We coordinate with the patient's gynaecologist or endocrinologist when systemic anti-androgen therapy is being considered, and limit our scope to topical and supportive measures unless that loop is closed.
Dandruff & Scalp Inflammation
Often co-exists with hair fall. Seborrheic dermatitis, scalp psoriasis and contact dermatitis are differentiated by history and trichoscopic signs. Antifungal or anti-inflammatory regimens are sequenced before growth-stimulating actives in inflamed scalps.
Alopecia Areata & Scarring Alopecias
Patchy and scarring presentations are routed to in-person care. Telemedicine is not the right setting for steroid injections, biopsy or immunosuppressive therapy, and we will not attempt to manage these through the platform alone.
5. Evidence & Compliance
- Recommendations are mapped to IADVL(Indian Association of Dermatologists, Venereologists & Leprologists) consensus where available.
- Schedule H drugs are dispensed strictly per the Prescription Policy and CDSCO requirements.
- Telemedicine consultations follow the Telemedicine Practice Guidelines, 2020.
- Drug safety, side-effect profiles and pregnancy categorisation are surfaced in our Drug Safety Disclaimer before purchase.
- Personal and image data is handled per the Privacy Policy in line with the DPDP Act, 2023.
6. Important Medical Disclaimer
⚕️ The Hairsncares clinical framework is a structured aid to care — not a substitute for in-person medical examination. The AI engine is not a registered medical device. Teleconsultation has known limitations (no scalp biopsy, no in-person trichoscopy, no laboratory access in real time). No outcome is guaranteed. For severe, sudden or atypical hair loss, scalp pain or skin changes, see a registered dermatologist in person. Read the full Medical Disclaimer before relying on any AI output.
🚨 Hairsncares is not an emergency service. For any medical emergency call 112 or proceed to your nearest hospital immediately.
Related Guides and Next Steps
Where to go next on Hairsncares for this topic.